Unknown

Dataset Information

0

Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population.


ABSTRACT: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for advanced Parkinson's disease (PD). The G2385R variant of LRRK2 is a risk factor for PD in Han Chinese individuals. We retrospectively compared the clinical outcomes of STN-DBS surgery between PD Han Chinese G2385R variant carriers and non-carriers. Fifty-seven PD patients with bilateral STN-DBS were enrolled, including 8 G2385R+ variant carriers (G2385R+ group) and 49 non-carriers (G2385R- group). Clinical data included Unified Parkinson's Disease Rating Scale (UPDRS) parts I to IV, levodopa equivalent daily dose (LEDD), Mini-Mental State Examination Scale (MMSE) score, and Hamilton Depression Rating Scale (HAMD) score measured prior to DBS and 12 months post-DBS. DBS settings were also recorded. All PD patients benefited from STN-DBS surgery. There were no statistical differences between the two groups in terms of motor function, daily living activities, and LEDD reductions at 12 months post-DBS. The rigidity of the post-surgical G2385R+ group was significantly improved compared with that of the G2385R- group (P = 0.045). Post-surgical voltage in the G2385R+ group was significantly higher than that in the G2385R- group (P = 0.033). STN-DBS outcomes were not influenced by the LRRK2 G2385R variant in Han Chinese patients.

SUBMITTER: Chen S 

PROVIDER: S-EPMC6884002 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population.

Chen Si S   Liu Hong H   Wu Qian-Qian QQ   Xu Shu-Jun SJ   Li Wei-Guo WG   Chen Teng T   Li Chao C   Ma Xiang-Yu XY   Xu Shuo S   Liu Yi-Ming YM  

Frontiers in neurology 20191122


Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for advanced Parkinson's disease (PD). The G2385R variant of <i>LRRK2</i> is a risk factor for PD in Han Chinese individuals. We retrospectively compared the clinical outcomes of STN-DBS surgery between PD Han Chinese <i>G2385R</i> variant carriers and non-carriers. Fifty-seven PD patients with bilateral STN-DBS were enrolled, including 8 G2385R+ variant carriers (G2385R+ group) and 49 non-carriers (G2385R- g  ...[more]

Similar Datasets

| S-EPMC5567486 | biostudies-literature
| S-EPMC5095708 | biostudies-literature
| S-EPMC4103427 | biostudies-literature
| S-EPMC3413674 | biostudies-literature
| S-EPMC7560751 | biostudies-literature
| S-EPMC8453839 | biostudies-literature
| S-EPMC5988013 | biostudies-literature
| S-EPMC8421387 | biostudies-literature
| S-EPMC6581538 | biostudies-literature
| S-EPMC6178381 | biostudies-literature